Akari Therapeutics PLC (AKTX)

0.97 -0.03 (-2.99%) USD  |  NASDAQ  |  Dec 20, 16:00
0.95 -0.02 (-2.06%) After-Hours: 20:00
More

Akari Therapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
DBV Technologies SA --
Ascendis Pharma AS Upgrade
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC Upgrade

EV to Revenues Related Metrics

EV to Free Cash Flow Upgrade